Our mission is to solve easy EV charging across the Nordics. One app to find the best route, charging stops based on your preferences, charge at any operator, and get smart suggestions based on your behaviour. We seek to be at the forefront of EV technology. At the charger, in the car, and at home. Join us in becoming the #1 EV app!

To realize our vision of "better customer journeys", we bring our customers the smoothest content platform on the planet. Our mission is to empower content-savvy organizations to optimize the use of content through flexible tools for content management and distribution. We provide an API-first hub that enables our users to reuse it as digital assets. Our open, agile, and secure platform helps our users get the most value out of their content and streamline content workflows. We make daily operations easier for everyone involved—whether it is developers looking for fast and open technology, editors looking for full flexibility and powerful content management, or business people looking for a scalable and predictable platform.

Amby is a leading strategic talent partner to some of the most innovative companies in the world, enabling their business growth through a proven combination of recruitment infrastructure, operations, and data. We are committed to transforming industries through people and creating a more sustainable future for companies and talent. With over 10 years of experience, we provide the power to scale faster by issuing access to global best talent practices, insight, strategies, tools, and systems, as well as a certified team of recruitment, HR, and marketing professionals dedicated to delivering quality results aligned with your business targets and aspirations.

We improve the way the shipping industry works and communicates. The whole industry is currently bogged down with unstructured emails and ship data.We have built a great ship database, and have a growing and happy customer base just from this. But we are not done. We are building communication tools on top of this, massively increasing the number of users we can help out!

Happii specializes in executive search, recruitment marketing, and talent management, with a focus on using tailored tools and processes to meet the specific needs of their clients. The company's approach emphasizes building strong relationships to understand and fulfill client goals. Connecting talent to opportunity with precision and a personal touch – that's Happii's magic

At Minuendo we are passionate about sound and the sense of hearing. We are equally concerned about the state of hearing for both consumers as well as professionals, ranging from musicians to workers in the construction industry. Minuendo was founded in 2018 by a team with extensive experience in acoustics, hearing protection, and product development. Our mission is to deliver category-defining hearing protection products that users will truly enjoy wearing and that will provide real protection.  Shortly after starting the company, we raised a total of EUR 2.5 million from investors such as Construct Venture and EU grants to accelerate our development. Minuendo is a fast-growing start-up based in Oslo. The founders have a track record of start-ups and product development. We have raised NOK 25 million since we started the company in the fall of 2018. We have offices in the loft at Pakkhuset close to Stortinget.  We are just about to launch our first product internationally and we need your help to make sure we succeed with product marketing and reaching users online that we otherwise would not have sold to through traditional channels. What we have made is a new high-end prosumer earplug that reduces noise and protects your hearing, while maintaining high fidelity of ambient sounds, such as music from your own instrument or at concerts. The technology and product are unique, and so must our digital marketing.

Vi er en objektivt og uavhengig avtalemegler. Mange bedrifter betaler unødvendig mye på for eksempel forsikring, telefoni, pensjon og posttjenester og andre innkjøp. Det er et bakteppe at det er mange aktører, med mye støyende reklame, liten skrift og skjulte vilkår. Ansatte i Skifta har over 20 års erfaring med forhandlinger, avtaler og markedsføring. Vi tar smerten ut av reforhandling av avtaler og gir bedriftsnorge bedre råd.

Ondego lets you charge your phone on the go through its network of portable batteries so you never have to worry about your battery level again. Users can find our chargers in cafés, restaurants, and other public locations where they can unlock a charger, charge wherever they want and later return to any Ondego station nearby. See this short video (1min) to see how it works:ondego.no

People find going to the optician frustrating and it is something they tend to delay as long as possible. Pain points include complicated, non-transparent pricing, lack of understanding about lenses and the options available, and insecurity when choosing glasses. Our mission is to remove these pain points and provide a more relevant modern alternative to the traditional optician. Our vertical concept allows us to offer high-quality designer eyewear at affordable prices - enabling people to build a collection of eyewear to meet the needs of their individual lifestyles. We are currently generating 14 million Nok in sales per year through our 5 Kaibosh stores (Oslo, Bergen, Copenhagen, Frederiksberg & Aarhus), e-commerce operation, and wholesale distribution channels.

Nutcracker Solutions owns the product StadiaPitch by Bosch Rexroth and have licensed it to Bosch Rexroth until 2038.  The product is sold worldwide by the Bosch Corporation, and Nutcracker is a part of Bosch`s International StadiaPItch sales team. The goal is to reach 4 sales a year. Bosch pays Nutcracker a license fee between €1M - €1.5M per sale. 90% of the fee is due 5 months after Bosch has signed the contract with the stadium. Nutcracker has a flat predictable annual operating cost of €0.4M, regardless of how many StadiaPitch Sales Bosch Rexroth has in that year.  StadiaPitch entered the commercial phase in 2018 and has received an overwhelming market response. StadiaPitch is today included in the architectural drawings on three stadium projects, and Bosch has solid interest from several of the largest clubs in the world. StadiaPitch has received interest from architects, stadiums, and other stakeholders from 25 countries in the last 12 months.  Nutcracker is a dividend stock and the company is priced at 40 MNOK – pre-money. Nutcracker runs a Private Placement of 1OMNOK through a share issue that will equal to 20% of the new total number of shares. This funding will be spent on IPR, activities that enhance Bosch`s global sales work, and operating costs until we get income from the first Bosch contract. We pay a preference dividend equivalent to 50% of the investment for new investors. We have a commitment of 9 MNOK and we close the placement when we reach after the NXT 2019 events.

VR is changing the way we learn with spacial mnemonics encoding trigging memory intimacy and presence - VR tech makes it possible to learn better and faster. Making View has the smartest and boldest people with an international company track record and solutions developed in cooperation with researches and clients. Making View is the improvisation master in the VR tech world creating harmonious learning environments - We will provide a scalable business model based on annual licenses.

WAKT er et oppstartsselskap basert i Drammen. Våre kompetanseområder ligger innenfor: Robotic Process Automation Development,Data EngineeringMachine LearningQuantitative financial Engineering and Analysis.Application Development Vi streber etter å ta i bruk moderne teknologi for å levere resultatene vi eller våre kunder er ute etter.

Iterate is an ecosystem for digital innovation, and we like to describe ourselves as a company that builds companies. We contribute from A-Z when building, starting with creating concepts based on key insights to launching and improving products whilst living in the marketplace. We find the right team and work toward the company culture that enables us to deliver value to our customers quickly. The key to achieving this is reinvesting all our profits in the ideas of our employees, or selected entrepreneurs. Five years into this strategy, we own shares in fifteen ventures; all of which are showing promising results. Our 70 designers, developers, and product managers just moved into new locations in the center of Oslo. 
Close collaboration with our customers is key to our success. They provide domain know-how, and we provide tools, strategies, and experts. Together we uncover the best way that connects your strategy and idea with the market needs. Our goal is to achieve minimum risk and give our customers the best possible starting point for scaling, on their own, or in continued collaboration.

Speak Norsk is an ambitious team that started with one goal in mind – to make expats fluent in Norwegian! We are passionate about language-learning and bringing to Norway a new, innovative way of teaching Norwegian. Since the beginning, we have been known for our interactive conversation-focused classes, own-written books, and something that it´s not quite common for other schools – a personal approach and a customized offer for each one of our students. Meet our passionate and united team of Speak Norsk school!

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.